Overview Financials News + Filings Key Docs Charts Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Quarterly results
Inv. presentation
|
|
Outset Medical, Inc. (OM)
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 10/12/2023 |
8-K
| Quarterly results |
| 08/16/2023 |
144
| Form 144 - Report of proposed sale of securities: |
| 08/16/2023 |
144
| Form 144 - Report of proposed sale of securities: |
| 08/16/2023 |
144
| Form 144 - Report of proposed sale of securities: |
| 08/16/2023 |
144
| Form 144 - Report of proposed sale of securities: |
| 08/16/2023 |
144
| Form 144 - Report of proposed sale of securities: |
| 08/16/2023 |
144
| Form 144 - Report of proposed sale of securities: |
| 08/16/2023 |
144
| Form 144 - Report of proposed sale of securities: |
| 08/02/2023 |
8-K
| Quarterly results|
Docs:
|
"Outset Medical, Inc. Condensed Statements of Operations Three Months Ended Six Months Ended June 30, June 30, 2023 2022 2023 2022 Revenue: Product revenue $ 29,330 $ 19,621 $ 57,109 $ 45,285 Service and other revenue 6,710 5,436 12,398 10,322 Total revenue 36,040 25,057 69,507 55,607 Cost of revenue: Cost of product revenue 22,212 17,718 43,029 40,828 Cost of service and other revenue 6,125 3,557 12,347 6,555 Total cost of revenue 28,337 21,275 55,376 47,383 Gross profit 7,703 3,782 14,131 8,224 Gross margin 21.4 % 15.1 % 20.3 % 14.8 % Operating expenses: Research and development 14,906 13,521 28,699 24,352 Sales and marketing 24,985 23,198 49,318 43,575 General and administrative 11,290 10,784 23,077 20,493 Total operating expenses 51,181 47,503 101,094 88,420 Loss from operations Inte..." |
|
| 08/01/2023 |
144
| Form 144 - Report of proposed sale of securities: |
| 08/01/2023 |
144
| Form 144 - Report of proposed sale of securities: |
| 07/19/2023 |
144
| Form 144 - Report of proposed sale of securities: |
| 07/07/2023 |
8-K
| Other Events, Financial Statements and Exhibits Interactive Data |
| 07/03/2023 |
144
| Form 144 - Report of proposed sale of securities: |
| 07/03/2023 |
144
| Form 144 - Report of proposed sale of securities: |
| 06/01/2023 |
144
| Form 144 - Report of proposed sale of securities: |
| 06/01/2023 |
144
| Form 144 - Report of proposed sale of securities: |
| 06/01/2023 |
8-K
| Submission of Matters to a Vote of Security Holders Interactive Data |
| 05/17/2023 |
144
| Form 144 - Report of proposed sale of securities: |
| 05/16/2023 |
144
| Form 144 - Report of proposed sale of securities: |
| 05/16/2023 |
144
| Form 144 - Report of proposed sale of securities: |
| 05/16/2023 |
144
| Form 144 - Report of proposed sale of securities: |
| 05/16/2023 |
144
| Form 144 - Report of proposed sale of securities: |
| 05/16/2023 |
144
| Form 144 - Report of proposed sale of securities: |
| 05/16/2023 |
144
| Form 144 - Report of proposed sale of securities: |
| 05/08/2023 |
144
| Form 144 - Report of proposed sale of securities: |
| 05/03/2023 |
144
| Form 144 - Report of proposed sale of securities: |
| 05/03/2023 |
144
| Form 144 - Report of proposed sale of securities: |
| 05/03/2023 |
144
| Form 144 - Report of proposed sale of securities: |
| 04/13/2023 |
DEFA14A
| Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material: |
| 04/13/2023 |
DEF 14A
| Form DEF 14A - Other definitive proxy statements: |
| 02/14/2023 |
SC 13G
| Bellevue Group AG reports a 5.9% stake in OUTSET MEDICAL, INC. |
| 02/14/2023 |
SC 13G/A
| PFM Health Sciences, LP reports a 0% stake in Outset Medical, Inc. |
| 02/13/2023 |
10-K
| Annual Report for the period ended December 31, 2022 |
|
|
|